 Dear Reader, The stock market just entered a highly dangerous new phase – which is going to have dramatic consequences for your money this summer. The signs are everywhere: SpaceX just went public. OpenAI and Anthropic will likely follow it. If you're thinking of buying into any of these IPOs... PLEASE DON'T. They're likely to be disasters – the most overhyped, overvalued large-cap stocks of all time, foisted on gullible investors by Wall Street insiders. At the same time, the President and his family are openly picking winners in the stock market... while a 24-year-old just founded his own hedge fund and made $5 billion in less than a year. But it's what's coming NEXT that I'm most worried about. I've spent 30 years on Wall Street. I have my MBA from Harvard and spend my time in correspondence with billionaires like Warren Buffett and Bill Ackman. I've forecast the collapse of dozens of stocks. But what I see happening today scares me – as a former money manager, as a father, and as an American. Because our country is headed toward an economic event unlike anything we've seen in over 100 years. Perhaps you see the signs too. Or maybe you just feel it – that creeping, nagging doubt that tells you something is dangerously wrong in our country. If that's you, I'd urge you... listen to your gut. If you care about your wealth, your family, and your future, you need to understand what's really coming. I've put together a free analysis explaining exactly what I see, and the specific steps I recommend you take with your money today. I strongly encourage you to check it out here. Regards, Whitney Tilson
Editor, Stansberry Investment Advisory
Former Hedge Fund Manager
Co-Founder, Teach for America
Harvard MBA P.S. What's happening today will reset the financial system in a way most of us can't imagine. If I'm even half-right, it's going to have a huge impact on your money and your future. Get the details here...
Featured News from MarketBeat
Rocket Lab’s Stock Drop Comes With a Bullish TwistAuthored by Ryan Hasson. First Published: 7/10/2026. 
Key Points
- Rocket Lab stock has dropped nearly 45% from its May peak, yet the company just completed a record-fast Space Force launch and on-orbit inspection mission for VICTUS HAZE.
- Morgan Stanley reiterated an Overweight rating and raised its bull-case target to $293, framing the $8 billion Iridium Communications acquisition as evidence Rocket Lab is becoming a smaller SpaceX.
- Bulls are defending the roughly $76 200-day moving average as support, with the August 6 earnings report expected to clarify Neutron's timeline, Iridium integration, and backlog trends.
- Special Report: The only metrics you should watch as a day trader.
Rocket Lab (NASDAQ: RKLB) has had a punishing stretch, to say the least. After peaking near $151 in May, the stock has fallen almost 45% from its record highs, closing at $82.55 on Thursday, July 10. The post-SpaceX (NASDAQ: SPCX) IPO rotation out of space stocks, a broader risk-off tape, and heavy insider selling have all weighed on the name. But beneath the ugly chart, the past two weeks have delivered some significant bullish fundamental developments. For long-term investors, the disconnect between price action and recent developments may be hard to ignore and could even signal a potential entry point. Mission Success in Record Time
Rocket Lab just delivered one of the more impressive operational feats in its history. As part of the U.S. Space Force's VICTUS HAZE mission, the company designed, built, and launched a spacecraft under tight deadlines, then executed a record-shattering responsive launch in just 16 hours and 42 minutes from notice to liftoff. The mission did not end there. Rocket Lab subsequently completed complex on-orbit rendezvous and proximity operations, proving its ability to track and inspect objects in space. That capability matters enormously. Responsive launch and on-orbit inspection sit at the heart of what the Pentagon wants from commercial space partners, and no other company outside SpaceX has demonstrated it at this level. It is exactly the kind of execution that can translate into future national security contracts, including work tied to the Golden Dome architecture and the Space-Based Interceptor program. Morgan Stanley Sees a Path to $293Despite the bearish price action and the steep sell-off, analysts remain steadfast. On July 8, Morgan Stanley raised its bull-case price target for Rocket Lab to $293 from $185, while reiterating an Overweight rating and a $105 base-case target. The bank's reasoning is straightforward: Rocket Lab is starting to look like a smaller SpaceX. The $8 billion acquisition of Iridium Communications, announced June 29, adds a global satellite network, L-band spectrum, and millions of recurring subscribers, continuing to transform Rocket Lab from a launch company into a vertically integrated space platform. As the analyst put it, the greatest value creation in the space economy comes not from launch alone, but from owning differentiated space-based infrastructure and monetizing recurring services. Reaching $293 would require a clean, on-time Neutron debut, successful Iridium integration, and major defense awards converting into signed contracts. But even the $105 base case implies meaningful upside from current levels, and the consensus price target of $108.24 across 21 analysts sits more than 31% above where the stock trades. The Technical Line in the SandFrom a technical perspective, the picture is simpler. After a 45% drawdown, the key line in the sand for bulls is the 200-day SMA, which sits around $76 per share. The stock has so far held above that level even through the worst of the selling. If it continues to defend that zone, a durable base could form, giving long-term buyers a defined-risk entry point. A decisive break below it, however, would put the broader uptrend that has been in place since early 2025 into genuine question. Until the stock reclaims higher levels, this remains a stabilization attempt rather than a confirmed reversal. One notable caution for investors is insider selling, which could continue to weigh on the stock’s price action. Insider sales have added to the negative sentiment, with CEO Peter Beck disclosing the sale of nearly 3 million shares over the past week. Insider sales after a massive multi-year run are not unusual, but the timing has not helped the tape. August 6: The Next Big CatalystQ2 earnings are expected to arrive on August 6, and the report gives management a chance to reset the narrative. Investors should focus on four things. First, revenue was guided to a range of $225 million to $240 million, which came in well above consensus when issued. Second, any update on Neutron's debut timeline, the single most important variable in the Morgan Stanley bull case. Third, commentary on the Iridium deal, including the closing timeline and early integration planning. And fourth, backlog growth, which stood at a record $2.2 billion last quarter. For long-term investors, the setup is compelling but conditional. The business is executing at the highest level in its history, the analyst community sees substantial upside, and the stock is down almost 45% from its peak. If the 200-day SMA holds and the August 6 report confirms the fundamental trajectory, this pullback may eventually be remembered as the opportunity it increasingly appears to be.
This ad is sent on behalf of Stansberry Research, 1125 N Charles St, Baltimore, MD 21201. If you would like to optout from receiving offers from Stansberry Research please click here.
. |
